Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIqgeo Regulatory News (IQG)

Share Price Information for Iqgeo (IQG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 470.00
Bid: 464.00
Ask: 476.00
Change: 0.00 (0.00%)
Spread: 12.00 (2.586%)
Open: 470.00
High: 470.00
Low: 470.00
Prev. Close: 470.00
IQG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Nov 2015 07:00

RNS Number : 4315F
Ubisense Group PLC
12 November 2015
 

12.11.15

 

Ubisense Group PLC (the "Company")

 

Trading Update

 

Ubisense ("Ubisense" or the "Company") (LON:UBI), a market leader in enterprise location intelligence solutions, announces an update on current trading and an outlook for the current financial year ending 31 December 2015 ("FY15").

 

The Geospatial division has continued to trade satisfactorily. There is some significant deal concentration weighted towards the final weeks of FY15, in addition there is a good pipeline of opportunities to close for both FY15 and 2016. During the period the Company deployed with a number of its strategic partners, demonstrating ongoing demand for its solutions as well as validating its partner channel approach.

 

The RTLS division has been materially impacted by the recent well-publicised challenges facing the Company's large automotive customers, in Germany especially, and this has resulted in the downscaling, delay or cancellation of certain major deployment contracts and a likely lengthening of customer decision cycles in the wider industry.

 

Due to these unforeseen circumstances, there is a risk of a material revenue and subsequent profit shortfall against previous guidance for FY15. The Board's estimate is that second half revenues will now be in the range of £12.6-14.6 million (as against first half revenues of £10.4 million) and that full year FY15 revenues will therefore be in the range of £23-25 million. This range of outcomes should result in at least a small positive adjusted EBITDA for the second half, before non-recurring costs, but an adjusted EBITDA loss for the full year FY15.

 

As previously announced and as part of the stated strategic restructuring, the Board implemented some significant cost reduction initiatives early in the second half, resulting in annualised savings of £2.0 million. Given the challenging trading conditions highlighted above, the Board has decided to implement further cost actions over the coming months, with a view to achieving further annualised savings of approximately £3 million. A further exceptional charge of £1.7 million is expected in the second half of FY15 in relation to these measures, bringing the total exceptional charge in FY15 to £3.6 million.

 

Cash conversion this year has been adversely affected by restructuring costs and extended payment terms on certain contracts, impacting the collection of receivables. Gross cash at the end of October 2015 was £4.8 million, with £5.3 million drawn under the Company's available debt facilities, giving a net debt position of £0.5 million. The Company expects to remain in a gross cash, but net debt position, as at 31 December 2015. Management is in regular dialogue with its principal lender, HSBC, who remain supportive and in constructive discussion to support the Company's on-going requirements. The Board is determined to ensure that the Company's cash outflow situation is rectified though improved cash conversion in 2016, coupled with the benefits of the recent and current cost alignment initiatives.

 

Peter Harverson, Chairman designate, commented:

 

"The second half of the period has been challenging for the business, driven by macro events outside of our control. Whilst disappointing to announce a reduced revenue number, the recent signing of a new automotive OEM in Spain through Atlas Copco and other strategic wins support the Board's view that the strategy in place means the Group is well positioned moving forward.

 

In the short-term, we have made some necessary decisions to right size the cost base of the business and are focused on refining our sales strategy, in particular our partner channel development, to drive revenue growth through expanded scale and reach."

 

Contact

Ubisense Group plc Tel: + 44 (0) 1223 535170

Richard Green

Tim Gingell

 

Numis Securities Limited  Tel: + 44 (0) 207 2601000

Simon Willis, Jamie Lillywhite (Corporate Finance)

Rupert Krefting (Corporate Broking)

 

Redleaf Communications   Tel: +44 (0) 20 7382 4730

Rebecca Sanders-Hewett, Richard Gotla,

David Ison, Harriet Lynch

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKDDBKBDBADD
Date   Source Headline
31st Mar 20174:14 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
29th Mar 20177:00 amRNSDirectors' Dealings
27th Mar 20177:00 amRNSDirectors' Dealings
22nd Mar 20177:00 amRNSDirectors' Dealings
21st Mar 20177:00 amRNSFinal Results
16th Mar 20177:00 amRNSNotice of Results
1st Mar 20172:39 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
27th Feb 20175:07 pmRNSTR-1: Notifications of Major Interests in Shares
8th Feb 20177:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
27th Jan 20177:00 amRNSTrading Statement
3rd Jan 20177:00 amRNSBlock listing Interim Review
15th Dec 20167:00 amRNSAppointment of CEO
15th Dec 20167:00 amRNSDirectors Dealings
25th Nov 20165:37 pmRNSDirectors' Dealings
8th Nov 20167:00 amRNSDirectors' Dealings
27th Oct 20164:18 pmRNSDirectors' Dealings
14th Sep 20167:00 amRNSDirector/PDMR Shareholding
16th Aug 20167:00 amRNSInterim Results
10th Aug 20167:00 amRNSAppointment of CFO
1st Jul 20167:00 amRNSTotal Voting Rights
22nd Jun 201611:02 amRNSResult of AGM
27th May 20167:00 amRNSNotice of AGM
18th May 20167:00 amRNSDirector resignation & appointment
28th Apr 201611:28 amRNSHolding(s) in Company
27th Apr 20162:58 pmRNSHolding(s) in Company
26th Apr 20165:48 pmRNSHolding(s) in Company
26th Apr 20168:00 amRNSDirector's Dealing
25th Apr 20163:18 pmRNSResult of General Meeting
7th Apr 201610:40 amRNS£4.8 million placing
7th Apr 201610:33 amRNSFinal Results
17th Mar 20167:00 amRNSNotice of Results
17th Mar 20167:00 amRNSNew contracts
9th Feb 20167:00 amRNSHolding(s) in Company
25th Jan 20167:00 amRNSTrading Statement
4th Jan 20167:00 amRNSBlocklisting Interim Review
4th Jan 20167:00 amRNSTotal Voting Rights
2nd Dec 20159:20 amRNSDirector/PDMR Shareholding
2nd Dec 20157:00 amRNSHolding(s) in Company
2nd Dec 20157:00 amRNSHolding(s) in Company
1st Dec 20157:00 amRNSTotal Voting Rights
27th Nov 20157:00 amRNSHolding(s) in Company
27th Nov 20157:00 amRNSHolding(s) in Company
23rd Nov 20157:00 amRNSHolding(s) in Company
12th Nov 20157:00 amRNSTrading Update
2nd Nov 20157:00 amRNSTotal Voting Rights
2nd Oct 20157:00 amRNSTotal Voting Rights
16th Sep 20157:00 amRNSHolding(s) in Company
2nd Sep 201511:45 amRNSTotal Voting Rights
1st Sep 20157:04 amRNSHolding(s) in Company
17th Aug 20157:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.